CGN — Cognetivity Neurosciences Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Cognetivity Neurosciences, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.379 | 0.578 | 1.36 | 1.38 | 2.24 |
| Net Total Receivables | 0.057 | 0.047 | 0.082 | 0.432 | 0.371 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.69 | 0.711 | 1.75 | 1.86 | 2.66 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.026 | 0.037 | 0.044 | 0.063 | 0.062 |
| Net Intangible Assets | |||||
| Total Assets | 0.716 | 0.748 | 1.83 | 2 | 2.83 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.237 | 1.01 | 0.965 | 5.56 | 10.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.237 | 1.01 | 0.965 | 7.68 | 12.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.479 | -0.263 | 0.863 | -5.68 | -9.89 |
| Total Liabilities & Shareholders' Equity | 0.716 | 0.748 | 1.83 | 2 | 2.83 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |